Last Updated on June 29, 2024 by The Health Master
Drug recall
If you take medication for low potassium levels (hypokalemia), be aware of a recent drug recall by Glenmark Pharmaceuticals Inc., USA.
They are voluntarily recalling 114 batches of their Potassium Chloride Extended-Release Capsules (750mg) due to a serious quality control issue.
Risk of High Potassium Levels (Hyperkalemia)
The drug recall is due to “failed dissolution,” which means the capsules may not release the potassium chloride medication properly.
This could lead to dangerously high potassium levels in your blood, also known as hyperkalemia.
Potential Complications of Hyperkalemia
Hyperkalemia is a serious medical condition that can cause a range of health problems, including:
- Irregular heartbeat (arrhythmias)
- Muscle weakness, which can be severe
- Cardiac arrest (sudden death)
Who is Most at Risk?
The risk of hyperkalemia is especially high for patients who:
- Take Potassium Chloride Extended-Release capsules chronically
- Have underlying health conditions like high blood pressure (hypertension), heart failure, or kidney problems (renal dysfunction)
What to Do if You’ve Taken the Recalled Medication
- Stop taking the medication immediately.
- Consult your doctor to discuss alternative treatment options and to monitor your potassium levels.
- Check the lot number of your Potassium Chloride Extended-Release Capsules. A list of recalled batches can be found on the FDA website.
Important Note:
- Glenmark Pharmaceuticals has not received any reports of hyperkalemia or serious adverse events related to this recall yet. However, it’s crucial to be aware of the potential risks and take action to protect your health.
Additional Information
- The recalled capsules are packaged in bottles of 100 (NDC 68462-357-01) and 500 (NDC 68462-357-05) capsules.
- The capsules were distributed nationwide to wholesalers, distributors, and retail outlets across the United States.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Drug recall: Lupin, Eugia recalled products Due to Manufacturing Issues
Drug recall: 51k bottles of generic Antibiotic Drug recalled
Drug recall: Dr Reddy’s, Sun Pharma, Aurobindo recall these drugs due to this reason
Drug recall: Cipla, Glenmark recall these drugs
Drug recall: This Dietary Supplement recalled due to the Presence of Nortadalafil
Drug recall: 7 lots of Treprostinil injection recalled due to this reason
Fire At Pharma Factory In Rajasthan
Telangana DCA Uncover Illegally Manufactured “Nutraceuticals”
USFDA issues positive EIR to Lupin Limited
Govt expands Committee for Drug & Medical Device Pricing
USFDA issues Form 483 with 4 observations to Biocon
Drug recall: Lupin, Eugia recalled products Due to Manufacturing Issues
Exploring Himachal Pradesh’s New Bulk Drug Park
Drug alert: 52 drug samples declared as NSQ in May 2024
Nutraceutical Manufacturing in Drug Facilities: 5 members committee formed
USFDA issues Form 483 with 6 observations to Cipla for Goa facility
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
